BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 32180141)

  • 1. Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer.
    Solis-Castillo LA; Garcia-Romo GS; Diaz-Rodriguez A; Reyes-Hernandez D; Tellez-Rivera E; Rosales-Garcia VH; Mendez-Cruz AR; Jimenez-Flores JR; Villafana-Vazquez VH; Pedroza-Gonzalez A
    Breast Cancer; 2020 Sep; 27(5):837-849. PubMed ID: 32180141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodal status in luminal A invasive breast cancer: relationships with cytotoxic CD8 + and regulatory FOXP3 + cells tumor-associated infiltrate and other prognostic factors.
    Glajcar A; Łazarczyk A; Tyrak KE; Hodorowicz-Zaniewska D; Streb J; Okoń K; Szpor J
    Virchows Arch; 2021 Nov; 479(5):871-882. PubMed ID: 34117905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
    Stenström J; Hedenfalk I; Hagerling C
    Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
    Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
    Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement.
    Macchetti AH; Marana HR; Silva JS; de Andrade JM; Ribeiro-Silva A; Bighetti S
    Clinics (Sao Paulo); 2006 Jun; 61(3):203-8. PubMed ID: 16832552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GITR-expressing regulatory T-cell subsets are increased in tumor-positive lymph nodes from advanced breast cancer patients as compared to tumor-negative lymph nodes.
    Krausz LT; Fischer-Fodor E; Major ZZ; Fetica B
    Int J Immunopathol Pharmacol; 2012; 25(1):59-66. PubMed ID: 22507318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer.
    Battaglia A; Buzzonetti A; Baranello C; Ferrandina G; Martinelli E; Fanfani F; Scambia G; Fattorossi A
    Cancer Immunol Immunother; 2009 Sep; 58(9):1363-73. PubMed ID: 19172271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of TIM-3 expression by CD4
    Shariati S; Ghods A; Zohouri M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
    Mol Immunol; 2020 Dec; 128():47-54. PubMed ID: 33068833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low mutation and neoantigen burden and fewer effector tumor infiltrating lymphocytes correlate with breast cancer metastasization to lymph nodes.
    Wang Z; Liu W; Chen C; Yang X; Luo Y; Zhang B
    Sci Rep; 2019 Jan; 9(1):253. PubMed ID: 30670769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status.
    Glajcar A; Szpor J; Hodorowicz-Zaniewska D; Tyrak KE; Okoń K
    Virchows Arch; 2019 Jul; 475(1):13-23. PubMed ID: 31016433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma.
    Minárik I; Lašťovička J; Budinský V; Kayserová J; Spíšek R; Jarolím L; Fialová A; Babjuk M; Bartůňková J
    Immunol Lett; 2013 May; 152(2):144-50. PubMed ID: 23721909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
    Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
    Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer.
    Takada K; Kashiwagi S; Asano Y; Goto W; Kouhashi R; Yabumoto A; Morisaki T; Shibutani M; Takashima T; Fujita H; Hirakawa K; Ohira M
    BMC Cancer; 2020 Jun; 20(1):598. PubMed ID: 32590956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Follow-up After Interstitial Laser Thermotherapy of Breast Cancer.
    Haraldsdóttir KH; Ingvar C; Stenram U; Tranberg KG
    Anticancer Res; 2015 Nov; 35(11):6147-52. PubMed ID: 26504041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
    Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC
    J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.
    Faghih Z; Erfani N; Haghshenas MR; Safaei A; Talei AR; Ghaderi A
    Immunol Lett; 2014; 158(1-2):57-65. PubMed ID: 24326038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of dendritic cell subpopulations in follicular lymphoma with respect to the tumor immune microenvironment.
    Chevalier N; Mueller M; Mougiakakos D; Ihorst G; Marks R; Schmitt-Graeff A; Veelken H
    Leuk Lymphoma; 2016 Sep; 57(9):2150-60. PubMed ID: 26757600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.
    Zhu S; Lin J; Qiao G; Xu Y; Zou H
    Tumour Biol; 2015 Sep; 36(10):7907-13. PubMed ID: 25953262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival.
    Sorrentino C; Yin Z; Ciummo S; Lanuti P; Lu LF; Marchisio M; Bellone M; Di Carlo E
    J Immunother Cancer; 2019 Jul; 7(1):201. PubMed ID: 31366386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.